# The Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994, Paragraph 5


Until 31st March 1995 the Medicines (Products for Human Use—Fees) Regulations 1991 shall have effect as if—
(a) any reference to a product licence or to licences under Part II of the Act included a reference to a United Kingdom marketing authorization;
(b) in regulation 2(1), the definition of “medicinal product” included a reference to a relevant medicinal product;
(c) in regulation 7, the reference to an application under section 30 of the Act to vary a product licence included a reference to an application under regulation 4 above to vary a United Kingdom marketing authorization; and
(d) in head 1(a)(i) in Column 1 of the Table in Part II of Schedule 1, paragraphs 2 and 2A of Part III of that Schedule and in the definition of “limited use drug” in paragraph 1 of Part I of Schedule 3, the references to paragraph 5 of Schedule 2 to the Applications Regulations included references to section G of Part 4 of the Annex to Council Directive 75/318/EEC.

---
Source: https://www.legislation.gov.uk/uksi/1994/3144/schedule/6/paragraph/5 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-marketing-authorisations-etc-regulations-1994/schedule-6/paragraph-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.